Agio


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia, Wikipedia.

Agio

1. See: Foreign exchange.

2. A fee paid to a bank or other intermediary for exchanging two currencies.
References in periodicals archive ?
For Agio, this information lets them know what's working and what isn't.
Apart from delivering financial benefits to Agios, Penn and the Abramson Family Cancer Research Institute, it would also be beneficial to cancer patients.
Agios has multiple first-in-class programs in cancer metabolism and inborn errors of metabolism advancing toward the clinic, in addition to an active research and discovery pipeline across both therapeutic areas.
In the article, Agios scientists reported the first inhibitors of mutant IDH1 that show good potency in a glioblastoma cell line harboring IDH1 mutation and achieve robust tumor 2-HG inhibition in the tumor xenograft model.
The important discovery by Agios and the publication of the Nature article solidifies Agios' leading role in cancer metabolism," Michael Hui, founder and CEO of ChemPartner commented.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, announced today two recent publications that provide important new validation for the emerging field of cancer metabolism.
ChemPartner) a wholly owned subsidiary of ShangPharma Corporation, today announces that it has expanded its integrated drug discovery research collaboration with Agios, the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of cancer metabolism.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in cancer metabolism, announced today the publication of a new study that provides further evidence of the link between a mutated metabolic enzyme and acute myeloid leukemia (AML), one of the most common types of leukemia in adults.
To support and drive these efforts, Agios has built a robust platform integrating cancer biology, metabolomics, biochemistry and informatics to enable target and biomarker identification.
The strength of our science and success of our efforts to date are a direct result of the amazing people at Agios," said Duncan Higgons, chief operating officer of Agios.